Finance

Lists
HBIO:NASDAQ
Harvard Bioscience Inc
$7.54
+6.50%
(+0.46) 1D
Aug 20, 3:13:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HBIO...
Open
$6.94
High
$7.63
Low
$6.94
Mkt. cap
34.70M
Avg. vol.
16.46K
Volume
45.81K
52-wk high
$9.40
52-wk low
$3.78
EPS
-$2.32
Beta
1.49
Shares outstanding
4.55M
No. of employees
328
Open
$6.94
High
$7.63
Low
$6.94
Mkt. cap
34.70M
Avg. vol.
16.46K
Volume
45.81K
52-wk high
$9.40
52-wk low
$3.78
EPS
-$2.32
Beta
1.49
Shares outstanding
4.55M
No. of employees
328
News stories
From web sources and news partners
Profile
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany. Wikipedia
About Harvard Bioscience Inc
CEO-
Employees328
Founded1901
HeadquartersHolliston, Massachusetts, United States
SectorHealth care
Websiteharvardbioscience.com
Analyst
Recommendation
Action
Price target
Projected
Date
Bruce Jackson
Benchmark Co.
Buy
Maintained
$6.00
-20.4%
03/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
20.59M
23.74M
20.76M
22.73M
Cost of goods sold
8.57M
9.56M
8.51M
10.10M
Cost of revenue
8.57M
9.56M
8.51M
10.10M
Research and development expenses
2.13M
2.18M
2.33M
2.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.79M
7.81M
10.04M
10.02M
Operating expense
11.78M
10.85M
13.18M
13.29M
Total operating expenses
20.35M
20.41M
21.69M
23.39M
Operating income
245.00K
3.32M
-939.00K
-660.00K
Other non operating income
-365.00K
-3.95M
-405.00K
-
EBT including unusual items
-1.13M
-3.20M
-3.31M
-2.90M
EBT excluding unusual items
-1.09M
-2.99M
-3.07M
-2.58M
Income tax expense
97.00K
-357.00K
117.00K
14.00K
Effective tax rate
-8.55%
11.14%
-3.54%
-0.48%
Other operating expenses
-
-
-
-
Net income
-1.23M
-2.85M
-3.42M
-2.91M
Net profit margin
-5.98%
-11.99%
-16.50%
-12.80%
Earnings per share
-
-
-0.33
-0.14
Interest and investment income
-
-
-
-
Interest expense
-966.00K
-2.36M
-1.73M
-1.79M
Net interest expenses
-966.00K
-2.36M
-1.73M
-1.79M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.57M
4.68M
411.00K
715.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps